Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianji 888 is a multi-ingredient dietary supplement marketed primarily for male sexual enhancement and the improvement of vitality. It is widely distributed in the Chinese market and through various international online retailers. The product typically claims to be formulated from traditional Chinese medicinal (TCM) ingredients, including extracts from *Panax ginseng*, *Cynomorium songaricum*, and *Cordyceps sinensis*. Despite its marketing as a natural health product, Tianji 888 and similar '888' branded supplements have been frequently identified by health regulatory agencies as containing undeclared synthetic pharmaceutical ingredients, specifically phosphodiesterase-5 (PDE5) inhibitors such as sildenafil. These adulterants pose significant health risks, particularly to individuals with underlying cardiovascular conditions. It is not a registered pharmaceutical drug and lacks clinical validation for safety and efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tianji 888.